'Frankenstein' rabbits appear in two more states
Wildlife officials have urged people who see any rabbits with these growths to stay away and not touch them . The DNA-altering virus spreads when mosquitoes, ticks, or fleas bite an infected rabbit and then transmit CRPV to other rabbits. Since mosquito and tick seasons peak during the warmer summer months, cases of the potentially fatal condition could soon skyrocket throughout the Midwest. After being spotted multiple times in Fort Collins, Colorado, users on Reddit have now reported seeing infected rabbits near the major cities of St Paul and Minneapolis.
'My neighborhood is filled with cottontails with Shope papillomavirus,' one St Paul resident said on Reddit last month. 'Same in Minneapolis. By mid-late summer it seems all the surviving new rabbits have it,' another Reddit user replied. Other Minnesota residents noted that rabbits who did not show signs of the virus had actually become a rarity in the area. Scientists noted that CRPV rarely spreads through direct contact between these rabbits, and there are no known cases of insects infecting people with it through a bite.
The first sign that a rabbit has the virus is red, raised spots on their skin that eventually turn into wart-like tumors. In many cases, these warts develop into keratinized papillomas, the 'horns' and 'tentacles' seen growing out of rabbits' heads. However, some of the warts can turn into a squamous cell carcinoma, a serious skin cancer that can be deadly if it spreads and isn't treated early. After the recent sightings in Colorado, state parks and wildlife officials noted that other pets, such as dogs and cats, should be immune to the infection as well.
Fort Collins resident Susan Mansfield compared the tumors to 'black quills or black toothpicks' sticking out of the rabbits, adding that local witnesses thought the animals would die off during the winter months, which did not happen. In Nebraska, residents also spotted tentacle-covered rabbits continuing to survive in the snow earlier this year. The virus is not thought to be painful unless the growths affect a rabbit's eyes or mouth, interfering with their ability to eat, causing them to die of starvation. Some on social media have questioned whether euthanizing infected wild rabbits would stop the spread.
'Is it more humane to kill them when [they're] like that or just leave them alone?' one person posted on Reddit. 'Put him out of his misery,' another person declared. Despite some people feeling that it would be compassionate to end the rabbits' suffering, animal control officials in the US have not made any kind of recommendation supporting this Colorado Parks and Wildlife added that the virus does not pose a public health risk to people or other species, so the best course of action is to simply leave the rabbits alone.
Rabbits that contract the virus have often been the source of stories about the mythical 'jackalope,' which is a rabbit with antlers of an antelope. Stories and illustrations of horned rabbits have appeared in scientific books dating back many years, such as the Tableau encyclopédique et méthodique from 1789. Online, many people commenting on the recent explosion in CRPV sightings have referenced the mythical creature.
'So jackalope myths could have a realistic historical precedent?!' one person on Reddit asked. According to Smithsonian , taxidermist Douglas Herrick was credited with creating the jackalope myth after he and his brother Ralph mounted antelope horns on a jackrabbit they had killed in the 1930s. However, it's believed that the brothers from Wyoming may have been inspired to create the hoax after spotting real cases of CRPV in the wild.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Spectator
2 hours ago
- Spectator
Britain owes America for its ‘free' healthcare
'A friend of mine who's slightly overweight, to put it mildly, went to a drug store in London,' Donald Trump said aboard Air Force One. Earlier he had told reporters: 'He was able to get one of the fat shots. 'I just paid $88 and in New York I paid $1,300. What the hell is going on? It's the same box, made in the same plant, by the same company.'' You can see why the dealmaker-in-chief was irked. And when Trump is irked, someone usually pays the price. In May, the President signed an executive order for 'most-favoured-nation prescription drug pricing for American patients'. It was a warning to drug companies, as well as other countries, that Americans were tired of paying nearly three times more for the same medicines as patients abroad. The US is home to less than 5 per cent of the world's population and yet American consumers account for almost three-quarters of global pharmaceutical profits, because manufacturers heavily discount their drugs overseas and make up the difference by inflating prices in the States. As the President puts it, 'freeloading' foreign customers 'get a free ride'. He's not wrong. But while Trump may get his wish in stopping overseas health systems from getting cheaper deals, it's not obvious that profit–making companies will cut their prices in America. The more likely response is that they'll raise them everywhere else. Eli Lilly, the American pharmaceutical giant behind the weight-loss jab Mounjaro, has announced that from September the recommended retail price of its strongest monthly dose in Britain will leap from £122 to £330 – inflation of more than 170 per cent. The company knows the NHS won't actually pay that much: it has already negotiated substantial discounts for the doses it prescribes. But by hiking the list price on the highest dose (which relatively few patients use), while cutting the private deals on lower doses, Lilly can appease Washington and protect its market at the same time. For now, anyway. But demand is picking up. In Britain, around 1.5 million people are already on weight-loss drugs, with 90 per cent paying out of pocket. Most take Mounjaro, while a smaller number are on Wegovy, the sister drug to Ozempic. Novo Nordisk, the Danish manufacturer of Wegovy, has agreed to keep its UK price low for the time being. But costs will eventually be driven up for Wegovy users too if Mounjaro users, faced with a much bigger bill, convert to Wegovy en masse, squeezing supply. Fat loss clinics are already seeing a 500 to 600 per cent increase in Brits switching to Wegovy, which – come September – will cost half the price of Mounjaro. Trump's war on drug pricing will affect other areas of British medicine too. Weight-loss jabs have become the symbol of American pharma – and its many excesses – but they are by no means the only miracle drug we get for cheap. Take Casgevy, a US-made gene therapy that can treat the blood conditions beta thalassemia and sickle cell disease. One dose costs more than £1.6 million at list price. Thanks to its clout as the country's single dominant buyer, the NHS has secured a confidential – though significant – discount. Casgevy's eye-watering price is easy to justify: therapies at the frontier of medicine cost billions to develop. British politicians love to remind us that the UK is a world leader in life sciences, and in many ways that's true, but it's the US that is funding nearly half of all global life-sciences research and development. Trump, in typical fashion, wants the credit – or at least cheaper price tags. But drug makers won't cut their profits; they'll shrink everyone else's discounts. The NHS's bargaining power may shield patients for a time, but price rises are coming. UK officials know it, too. Even before the latest hikes on the fat jabs, government papers released alongside the US-UK trade talks in May noted that the NHS would look at the concerns of the President. No prime minister or health secretary could openly sign up to higher drug costs borne by the NHS, but they knew Trump had not finished going after what he considers to be unfair trade practice. The uncomfortable truth for the British is that as much as we mock US healthcare as extortionate and venerate our NHS as sacred, we live off America's excess. The American healthcare system is Britain's greatest scapegoat: it's absurdly expensive, highly inefficient and still doesn't manage to provide universal coverage. Indeed, it's the only healthcare system in the developed world that can distract from just how poor our own is: a 'National Health Service' that falls short of practically every standard and target set for it. The NHS survives only because we ignore its outcomes. Measure after measure shows that plenty of people are being failed by an expensive, yet decaying system. Britain spends around £36 billion a year on pharmaceuticals, £19 billion of that coming from the NHS. Medicines are already the health service's second-biggest expense after staff. But that number would be a lot higher without America. Britain may be world-class in medical research, but we spend just 0.3 per cent of GDP on drug research and development, compared with America's 0.8 per cent. American money makes Britain's drug research possible. And for years, until drugs lose their patent, Americans pay exorbitant costs which subsidise the NHS's bargain prices. This model which so annoys Trump perhaps helps explain why the NHS continues to enjoy such widespread public support, despite its many failures. We'll tolerate months-long waiting lists, worse survival chances and outdated facilities if we have cheap or 'free' access to life-changing medicines. But will we put up with the broken system if we have to start paying a fair whack for drugs, either directly at the pharmacy counter or indirectly through the increased taxation that would be needed to fund them? The government won't give up our bargain pricing without a fight. Quietly, and at significant political cost, health officials will roll out a new strategy. We're never going to pay American prices for drugs – the 'free at the point of use' funding model simply could not afford it. Instead, we'll try to make our research environment so attractive to manufacturers that they'll reward us by maintaining drug discounts. That's the real motivation behind Wes Streeting's planned reforms for the NHS, which are championed by his supporters as a way to improve the patient experience and attacked by his critics as a covert means of privatising the health service. Take the single patient record, which NHS England says will give 'every part of the NHS a full picture of the patient'. Perhaps – but it will also make it far easier to identify people for clinical trials and medical research. Look at the partnership between the Wellcome Trust and the government to create a £600 million health data research service. The stated aim is to 'simplify access to health data and speed up research'. But it also makes Britain an attractive place for pharmaceutical companies. The offer is simple: we'll make it as easy and welcoming as possible for you to do your research here, you've just got to keep paying for it. This is the part British politicians never want to say out loud, especially when it comes to healthcare: someone, somewhere, is always paying for it. Drugs aren't 'cheap'. The NHS isn't 'free'. There are always trade-offs: either higher prices, longer wait times, or uncomfortable deals and data swaps with Big Medicine. No matter how you spin it, Britain's 'free ride' is coming to an end.
Metro
4 hours ago
- Metro
'Mutant' deer covered in fleshy bubbles spotted in the US
This year has not been too kind to animals in the US. Americans have spotted so-called 'Frankenstein' rabbits oozing sluglike tentacles from their faces and 'zombie' squirrels covered in sores in their back yards in recent months. Now, social media users in New York, Pennsylvania and Wisconsin, among others, say they're seeing deer covered in fleshy bubbles. 'A white-tailed deer in Pennsylvania. But what is the growth? Is it a mole? A boil? An injury?' asked one Reddit user earlier this month. Clay Moden, a radio show host at WYRK in Buffalo, uploaded trail camera footage of a deer with 'some sort of growth on it' in early August. Don't go sprinting to your bunker out of fear we've got a Last of Us fungal plague on our hands, though. The deer are infected with deer cutaneous fibroma, a mostly benign infection that can't spread to other species, including humans. Better known as deer warts, this strain of fibroma is mainly found in young white-tailed deer and mule deer. It can cause up to two dozen hairless tumours to appear on the animal's body. The warts, sometimes as small as a pea to as large as a football, pop up on a deer's head, neck and forelegs. These lumps don't cause the deer any pain, but can hinder their ability to walk, eat or see. Deer generally overcome the disease on their own within a few months, as the growths slowly dry up and fall off. One user on X noted last Thursday: '…This deer in my yard. [The warts] got worse, then three months later, they were gone.' There's no known cure or treatment and it's recommended impacted deer be left alone. But if a deer is particularly struggling because of the warty lesions, you should call your local wildlife agency. Fibroma is transmitted through biting insects, such as mosquitoes, so deer are more likely to contract it in the summer and autumn, when the bugs are most active. Deer can also be sickened with fibroma by directly contacting a surface where the virus is wriggling on, or by rubbing against an infected deer. The creatures often trot along the same trails or nibble from the same feeding spots, making transmission possible. 'Fibromas are more commonly seen in male deer, suggesting that fighting may play a role in transmission of the virus,' according to the Cornell Wildlife Health Lab. The Maine Department of Inland Fisheries and Wildlife advises that hunters who harvest an infected deer skin the animal. The infection caused a scare in 2019, when viral Facebook posts blamed the bulbous deer on a brand of weedkiller, which is not the case. Many mammals have their own version of deer warts, called papillomas. Papillomaviruses are behind the recent cases of cottontail rabbits covered in black spikes, which are also spread by mosquitoes and ticks. This includes humans, too – human papillomavirus (HPV), a common sexually transmitted infection, can cause genital warts. Dr Omer Awan of the University of Maryland School of Medicine told MailOnline that we might be seeing more 'gross' pictures of animals in the future for two reasons. More Trending As humans continue to burn fossil fuels, spewing planet-warming pollution into the air, climate change will make the Earth warmer, helping blood-sucking critters like mosquitoes to thrive. But another reason for any increases in sightings might not seem as obvious. 'People are starting to talk about it more, they're starting to document it more on social media,' Dr Awan said. 'Hence, there's been a lot more discussion about this.' Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page. MORE: Toxic vapor kills fifth person in New York City MORE: Map shows Hurricane Erin along US East Coast threatening to isolate barrier islands MORE: Food influencers narrowly escape death after car crashes into restaurant table mid-review
Daily Mail
4 hours ago
- Daily Mail
Mutant deer with horrifying flesh bubbles spotted in multiple US states as fears of an outbreak grip the nation
Deer across the US have been spotted with tumor-like growths hanging off their bodies, joining rabbits and squirrels as animals showing signs of widespread disease. From the Northeast to the Pacific Northwest, pictures on social media continue to document cases of strange bubbles growing all over local deer, from their faces to their legs. Over the last two months, people have photographed deformed deer in New York, Pennsylvania, and Wisconsin. Wildlife officials have already identified the condition as deer cutaneous fibroma, better known as deer warts. The condition is due to a virus transmitted between deer in all parts of the US, and experts have warned that it's spreading this summer. The virus mainly spreads through disease-carrying insects like mosquitoes and ticks, which pass on the blood of infected deer to healthy animals nearby. Since these potentially deadly pests breed and multiply in warmer weather, Americans should expect to see more cases of the condition wherever deer may live. The Washington Department of Fish and Wildlife said: 'Papillomas are most frequently seen during the late summer and into the fall, probably due to increased biting insect activity during this time of year.' This year, Americans have also been encountering mutated rabbits and squirrels which have been spreading their own species-specific viruses throughout the US. These animals have dealt with similar sores and growths on their bodies as well. The condition spreading through deer this summer is part of the same broad family of viruses that can affect humans, known as papillomaviruses, which target the skin and mucous membranes. In humans, papillomaviruses cause conditions like common warts, plantar warts, and genital warts, and some strains are linked to cancers such as cervical or throat cancer. While both deer and human papillomaviruses lead to growths by infecting skin cells, the deer version is species-specific, meaning it's adapted only to infect deer and cannot jump to humans or other animals due to differences in how the virus attaches itself and enters cells in different species. Deer warts can be small, like a pea, or grow as big as a football, appearing gray, black, or fleshy and often hairless. While disease-transmitting insects are believed to be the main culprit spreading the virus, direct contact with the warts may also infect deer. Dr Kristin Mansfield, a wildlife veterinarian in Washington state, told FOX13 that deer can spread the virus if they share the same feeding areas, sleeping spot, or rubbing posts - usually a tree males use to mark their territory during mating season. Deer warts are found across the entire range of white-tailed deer in North America, so they're common throughout the US, with no specific state being much more affected than others. However, the condition is rarely fatal. The deer's immune system fights off the virus, and the warts shrink and disappear on their own after a few months. In rare cases, if the warts grow too large or become infected with bacteria, they can cause problems like blocking a deer's vision or ability to eat. One medical expert told the Daily Mail that Americans should expect diseases like this to continue spreading as temperatures get warmer throughout more of the year. Dr Omer Awan of the University of Maryland School of Medicine explained that climate change has allowed mosquitoes and ticks to live longer and also spread to areas they don't normally inhabit. While deer can't spread deer warts to people, they can bring illnesses such as Lyme disease to populated areas, which is passed on to humans through the ticks they carry. 'These temperature changes are resulting in diseases that were never endemic in certain areas to become endemic,' Dr Awan said. 'If you take a look at Lyme disease, for example, we're starting to see it in areas that we never saw it before... places like southern Canada, northern states on the East Coast, like Maine,' he added. Deer warts are not a new condition afflicting wildlife. Scientists believe it has been around for centuries, and studies on papillomaviruses affecting wildlife in the US go back to the 1950s. While climate changes in recent years are helping the virus to spread, Dr Awan noted that there's one other factor contributing to the increase in deer wart sightings: social media. 'People are starting to talk about it more, they're starting to document it more on social media, and hence, there's been a lot more discussion about this,' the doctor explained.
